
Type I zzso are implicated in the zzso of systemic lupus zzso zzso Type I zzso zzso are widely and zzso zzso in the periphery and involved zzso of a subset of zzso patients, and provide utility as zzso zzso to aid dose selection, as well as potential indicators of patients who might respond favorably to zzso therapy in zzso We implemented a zzso approach to identify a panel of type I zzso zzso to be used as potential zzso zzso to aid dose selection in clinical trials of zzso an zzso zzso zzso under development for the treatment of zzso In a zzso escalation phase 1 trial, we observed a zzso and zzso zzso of the zzso of type I zzso zzso in the blood of treated zzso zzso of expression of type I zzso zzso and proteins was also observed in skin zzso of zzso subjects from the same zzso zzso zzso resulted in a profound downstream effect in these zzso subjects that included suppression of zzso of zzso zzso factor belonging to the zzso family and the signaling pathways of zzso zzso zzso and zzso zzso factor in both the periphery and skin zzso A scoring method based on the expression of type I zzso zzso zzso zzso patients into two distinct zzso which suggests the possibility of using these type I zzso genes as zzso zzso to identify zzso patients who might respond more favorably to zzso I zzso zzso 

